Grünenthal GmbH presents tapentadol, a novel centrally acting analgesic, at the 25th Annual Scientific Meeting of The American Pain Society
Aachen (ots) - Tapentadol would be the first new molecular entity in the class of oral centrally acting analgesics to enter medical practice in over 25 years. At the American Pain Society Meeting in San Antonio, Texas, Grünenthal GmbH presented positive results on preclinical and early clinical studies of ...